Service Corporation International (NYSE:SCI)
Service Corporation International (NYSE:SCI) represented a move of 0.7 percent or $-0.47 per share and closed its previous day trading session at $46.2. 1.26 Million Shares were traded in the last trading session with an Average Volume of 1.22 Million Shares. The stock currently has a Market Capitalization of 8.3 Billion.
Service Corporation International, headquartered in Houston, Texas, is North America’s leading provider of deathcare products and services. Through their businesses, they market the Dignity Memorial(R) brand which offers assurance of quality, value, caring service, and exceptional customer satisfaction.
The stock traded between $35.19 and $46.34 over 1-Year time period showing its price to sales ratio of 2.61. Service Corporation International (NYSE:SCI) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $5.41 and 200-Day Simple Moving Average of $16.27. Its Price to Free Cash Flow is 23.28 and Price to Book of 5.61.
Analyst’s recommended the stock as 1.3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Service Corporation International (NYSE:SCI) reported its Actual EPS of $0.35/share. The analysts offering Earnings Estimates for the company were believing that Service Corporation International could bring EPS of $0.36/share. The difference between Actual EPS and Estimated EPS was -0.01 Percent. Thus showing an Earnings Surprise of -2.8 Percent.
Heron Therapeutics, Inc. (NASDAQ:HRTX)
In the last trading session, Heron Therapeutics, Inc. (NASDAQ:HRTX) added its value by 2.42% closing at the price of $28.73. The stock currently has market capitalization of 2.19 Billion, with average volume of 1.08 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Heron Therapeutics, Inc. (NASDAQ:HRTX) is showing beta of 1.46. This particular value of beta suggests that Heron Therapeutics, Inc. (NASDAQ:HRTX) has historically moved 146% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Heron Therapeutics, Inc. (NASDAQ:HRTX) is at $-2.92.
The stock currently has RSI of 53.52. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Heron Therapeutics, Inc. (NASDAQ:HRTX) topped its 52-week high price of $42.90 on 06/25/18 and 52-Week Low Price of $15.00 on 12/13/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.37% and monthly volatility of 6.56% respectively.